Expedition Medicines

Cambridge, United States

Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.

$50.0M raised

Oct 2025

Series A

Artificial Intelligence (AI)Biotechnology Chemical Engineering Generative AI

Top Investors

Flagship Pioneering

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Expedition Medicines

How much funding has Expedition Medicines raised?

Expedition Medicines has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are Expedition Medicines's investors?

Expedition Medicines's investors include Flagship Pioneering.

Where is Expedition Medicines headquartered?

Expedition Medicines is headquartered in Cambridge, United States.

What does Expedition Medicines do?

Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.

What stage is Expedition Medicines at?

Expedition Medicines is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2025.

MLA

"Expedition Medicines — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/expedition-medicines. Accessed July 2, 2026.

APA

VCBacked. (2025). Expedition Medicines — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/expedition-medicines

Wikipedia (cite web)

{{cite web |title=Expedition Medicines — Funding & Investors |url=https://www.vcbacked.co/company/expedition-medicines |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2025.